IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Management of Squamous Cell Carcinoma of the Lung
August 16, 2017 | Online

Overview

This program will provide an up-to-date, comprehensive review of the management of squamous cell non-small lung cancer.  With the introduction of the immune checkpoint inhibitors into current treatment algorithms, it is timely to address the new treatment paradigms for squamous NSCLC and the impact upon clinical practice.

What you should expect to learn

After attending this session, attendees will be able to:

  • Illustrate awareness of recently completed and ongoing clinical trials in squamous cell lung cancer;
  • Recognize of treatment paradigms incorporating immune checkpoint inhibitor therapies;
  • Assess knowledge in the decision-making process in the management of patients with squamous cell carcinoma. 

Corey J. Langer MD, FACP

Director of Thoracic Oncology
Abramson Cancer Center
Professor of Medicine
University of Pennsylvania 

Contact